Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.
about
Neuroplasticity and the next wave of antidepressant strategiesKetamine and other glutamate receptor modulators for depression in adultsA brief history of the development of antidepressant drugs: from monoamines to glutamateOral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case SeriesGlutamate and its receptors in the pathophysiology and treatment of major depressive disorderGlutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.[Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses : a systematic review].Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.Serial infusions of low-dose ketamine for major depression.Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one casesRosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial.Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia.Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart reviewNovel Glutamatergic Treatments for Severe Mood Disorders.Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.The effects of brain serotonin deficiency on behavioural disinhibition and anxiety-like behaviour following mild early life stress.A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.Acute antidepressant effects of intramuscular versus intravenous ketamine.Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderPathobiological targets of depression.Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.Sedoanalgesia in pediatric daily surgery.Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.New use for an old drug: oral ketamine for treatment-resistant depression.Mood Therapeutics: Novel Pharmacological Approaches for Treating DepressionCD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy.Neurobiological mechanisms of stress resilience and implications for the aged population.Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression.Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial.Glutamatergic Modulators in Depression.The role of glutamate in my professional life: from molecular neuroplasticity to the relief of suffering.A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.Effect of Ketamine on LTP and NMDAR EPSC in Hippocampus of the Chronic Social Defeat Stress Mice Model of Depression
P2860
Q21129480-8880D41B-3847-475A-9149-D7C50E2F37B4Q24186746-558BD92E-9996-4460-B5F2-4B4731885D17Q27028050-3EC32A60-4EC9-46FE-BC32-9BB1CB3AD966Q30491706-99221B79-B32B-4702-9B5C-17949390FECAQ30711088-73849757-A026-4D6A-B010-F4D65464D99BQ33874459-EE3F3669-739B-42DB-8B00-CA5D3341BA24Q34411641-A803831E-F639-4041-AFD0-8577FD50A496Q34475595-DCB156C7-EF27-434F-A44E-405F6D316E45Q34648663-E13F48DF-8D4D-44FE-AC68-EC22E9362CFEQ35020147-89EAE3B3-8B8D-4B16-9BEA-1D519E5F57ADQ35174211-B89BCC00-CAF1-4203-8390-3E4EF71F7D3DQ36035937-20FD9194-67E5-49A1-8D72-4AF427BCD54AQ36176755-7CFCA368-06B6-4CBC-AFA0-FEC4C05A64CFQ36498659-C60F960F-BE58-4A74-8AE3-157C6338419DQ36899381-30E1B726-B84D-4603-BC34-F6C8ADD2AD4BQ37029155-23FFDDD0-25C5-414D-9F21-CC2373C8D783Q37113859-06A3906C-6D3A-4F84-B8C4-D1EA85724BB3Q37596243-D526C83A-5CEF-4475-B0F9-4624B88D82E7Q37639101-C19F8524-B8D9-48B0-A32E-0046986AFB91Q37645989-253B1781-96F0-42A7-A509-DCBB6B1D0919Q37668014-DAF1C973-8A16-48D1-9D04-D67B3EAE84E1Q37831342-D1D0B9AD-C819-432A-9E8C-CC18AAF08C87Q38105535-9D49BDF1-84F7-4637-9963-A8BC7EC44461Q38128302-0CD00923-C69D-45F2-9E30-7B5287929C1EQ38837851-6649601B-1B13-4550-8E4B-D86D2829B994Q38917733-A844D7FF-25F9-4224-9DC5-B236473AE4EBQ38990885-30CCBD7E-AECD-4B62-A224-F2C3E6D5DB23Q39272309-BDC38271-09EB-48E8-A146-E396D5868B4BQ39311440-1847EA57-E125-40C7-AE0A-F5AD20A7108BQ44647972-2E0D7A6B-9CA7-44EC-BB07-FAFBC28E6F14Q47876654-31619C35-02AE-4BD7-AC7F-524C2938C9B1Q49712849-15CB5C0F-F592-4C5B-9AA1-A364A9E5591DQ50798113-7FE5A56B-CAC2-4C5E-9CAB-751D4733C43FQ55021143-91472C8A-D05D-40E4-BF4B-0DBA83EB5837Q57816585-CA113713-99DA-48ED-B146-BE337E983D39
P2860
Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Oral ketamine for the rapid tr ...... tients receiving hospice care.
@ast
Oral ketamine for the rapid tr ...... tients receiving hospice care.
@en
type
label
Oral ketamine for the rapid tr ...... tients receiving hospice care.
@ast
Oral ketamine for the rapid tr ...... tients receiving hospice care.
@en
prefLabel
Oral ketamine for the rapid tr ...... tients receiving hospice care.
@ast
Oral ketamine for the rapid tr ...... tients receiving hospice care.
@en
P2860
P356
P1476
Oral ketamine for the rapid tr ...... tients receiving hospice care.
@en
P2093
Alana Iglewicz
Scott A Irwin
P2860
P304
P356
10.1089/JPM.2010.9808
P577
2010-07-01T00:00:00Z